The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
Open accessAbstract
It is well established that high doses of monomeric immunoglobulin G (IgG) purified from pooled human plasma [intravenous immunoglobulin (IVIG)] confer anti-inflammatory activity in a variety of autoimmune settings. However, exactly how those effects are mediated is not clear because of the heterogeneity of IVIG. Recent studies have demonstrated that the anti-inflammatory activity of IgG is completely dependent on sialylation of the N-linked glycan of the IgG Fc fragment. Here we determine the precise glycan requirements for this anti-inflammatory activity, allowing us to engineer an appropriate IgG1 Fc fragment, and thus generate a fully recombinant, sialylated IgG1 Fc with greatly enhanced potency. This therapeutic molecule precisely defines the biologically active component of IVIG and helps guide development of an IVIG replacement with improved activity and availability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, galactose is required for sialylation with N-acetylneuraminic acid (NeuAc), which in turn can improve the solubility, anti-inflammatory activity, thermal stability and serum half-life of mAbs [8,23–26].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“it is the α2,6-linked NeuAc (main sialic acid linkage in human IgG) that is solely required for the anti-inflammatory activity of IgG mediated by non-canonical IgG-Fc receptors [24].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2056 · Cited by 2,032
Self-citationAnti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Self-citationThe Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,354
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,057
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,051
Self-citationGlycan-based interactions involving vertebrate sialic-acid-recognizing proteins
Varki, A. P. (2007) · Nature · doi:10.1038/nature05816 · Cited by 855
From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins
Korganow, A., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 691
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
Tumpey, T. M., Maines, T. R., Hoeven, N. V., Glaser, L. J., Solórzano, A., Pappas, C., Cox, N. J., Swayne, D. E., Palese, P., Katz, J. M., et al. (2007) · Science · doi:10.1126/science.1136212 · Cited by 580
Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N., & Raju, T. S. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.005 · Cited by 413
Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells
Ibricevic, A., Pekosz, A. S., Walter, M. J., Newby, C. M., Battaile, J. T., Brown, E. G., Holtzman, M. J., & Brody, S. L. (2006) · Journal of Virology · doi:10.1128/jvi.02677-05 · Cited by 399
Cited by
Sorted by citations
Items 501–600 of 847
Thomann, M., Malik, S., Kuhne, F., Avenal, C., Plath, F., Bonnington, L. S., Reusch, D., Bulau, P., & Cymer, F. (2019) · Bioanalysis · doi:10.4155/bio-2019-0124 · Cited by 16
Fcγ receptor biology and systemic lupus erythematosus
Jovanović, V., Xilei, D. A. I., Lim, Y. T., Kemeny, D. M., & MacAry, P. A. (2009) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2009.01426.x · Cited by 16
Sissy, M. H. E., El-Sissy, A. H., & Elanwary, S. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000089 · Cited by 16
Efficient Chemoenzymatic Synthesis of N‐Glycans with a β1,4‐Galactosylated Bisecting GlcNAc Motif
Weiss, M., Ott, D., Karagiannis, T., Weishaupt, M., Niemietz, M., Eller, S., Lott, M., Martínez‐Orts, M., Canales, Á., Razi, N., et al. (2020) · ChemBioChem · doi:10.1002/cbic.202000268 · Cited by 16
Self-citationRecent advances in antibody glycoengineering for the gain of functions
Liu, Z., Zou, X., Tang, F., & Huang, W. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102420 · Cited by 15
Miescher, S., & Käsermann, F. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.01.003 · Cited by 15
Pongrácz, T., Verhoeven, A., Wuhrer, M., & de Haan, N. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-020-09971-7 · Cited by 15
Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis
Cui, G., Li, R., Zhao, C., & Wang, D. W. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.769616 · Cited by 15
Viral and Host Biomarkers of HIV Remission Post Treatment Interruption
Giron, L. B., & Abdel‐Mohsen, M. (2022) · Current HIV/AIDS Reports · doi:10.1007/s11904-022-00607-z · Cited by 15
Harnessing IgG Fc glycosylation for clinical benefit
Archer, E. J., González, J. C., Ghosh, D., Mellins, E., & Wang, T. T. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102231 · Cited by 15
Pathobiont-driven antibody sialylation through IL-10 undermines vaccination
Tsai, C., Hajam, I. A., Caldera, J. R., Chiang, A. W. T., Gonzalez, C., Du, X., Choudhruy, B., Li, H., Suzuki, E., Askarian, F., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179563 · Cited by 15
Expression and function of the inhibitory Fcγ‐receptor in CIDP
Nimmerjahn, F., & Lünemann, J. D. (2011) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2011.00305.x · Cited by 15
Self-citationKodar, K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i23.3573 · Cited by 15
Antibody‐mediated sialidase activity in blood serum of patients with multiple myeloma
Bilyy, R. O., Tomin, A., Mahorivska, I., Shalay, O., Lohinskyy, V., Stoika, R. S., & Kit, Y. Y. (2010) · Journal of Molecular Recognition · doi:10.1002/jmr.1071 · Cited by 15
Can glycoprofiling be helpful in detecting prostate cancer?
Belický, Š., & Tkáč, J. (2015) · Chemical Papers · doi:10.1515/chempap-2015-0052 · Cited by 15
Dorokhov, Y. L., Sheshukova, E. V., Kosobokova, E. N., Shindyapina, A. V., Kosorukov, V. S., & Komarova, T. V. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916080058 · Cited by 15
Intravenous Immunoglobulin in Pediatric Rheumatology: When to Use It and What Is the Evidence
Rodriguez, M. M., & Wagner‐Weiner, L. (2017) · Pediatric Annals · doi:10.3928/19382359-20161214-01 · Cited by 15
Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues
Nandakumar, K. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030677 · Cited by 15
Capillary (Gel) Electrophoresis-Based Methods for Immunoglobulin (G) Glycosylation Analysis
Cajic, S., Hennig, R., Burock, R., & Rapp, E. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_4 · Cited by 15
New Opportunities in Glycan Engineering for Therapeutic Proteins
Zhong, X., D’Antona, A. M., Scarcelli, J. J., & Rouse, J. C. (2022) · Antibodies · doi:10.3390/antib11010005 · Cited by 16
Should development of Alzheimer¿s disease-specific intravenous immunoglobulin be considered?
Loeffler, D. A. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0198-z · Cited by 15
Lei, M., Quan, C. P., Wang, J. Y., Kao, Y., & Schöneich, C. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03010-2 · Cited by 15
Lo, K.-M., Léger, O. J. P., & Hock, B. M. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.aid-0007-12 · Cited by 14
Huang, H., Zeng, Y., Shivatare, V. S., Tseng, T., & Wong, C. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2423853122 · Cited by 14
Zlatina, K., & Galuska, S. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753294 · Cited by 14
Novel data analysis tool for semiquantitative LC-MS-MS2 profiling of N-glycans
Peltoniemi, H., Natunen, S., Ritamo, I., Valmu, L., & Räbinä, J. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9412-3 · Cited by 14
Myasthenia Gravis Treatment Updates
Cortés‐Vicente, E., Gallardo, E., Álvarez‐Velasco, R., & Illa, I. (2020) · Current Treatment Options in Neurology · doi:10.1007/s11940-020-00632-6 · Cited by 14
State-of-the-Art Glycomics Technologies in Glycobiotechnology
Pralow, A., Cajic, S., Alagesan, K., Kolarich, D., & Rapp, E. (2020) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2020_143 · Cited by 14
Kavur, M. M., Lauc, G., & Pezer, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00086-9 · Cited by 15
Current views on N-glycolylneuraminic acid in therapeutic recombinant proteins
Mastrangeli, R., Audino, M. C., Palinsky, W., Broly, H., & Bierau, H. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.004 · Cited by 14
Targeting B cells and autoantibodies in the therapy of autoimmune diseases
Kao, D., Lux, A., Schwab, I., & Nimmerjahn, F. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0427-7 · Cited by 14
Self-citationMolecular and Cellular Pathways of Immunoglobulin G Activity In Vivo
Nimmerjahn, F. (2014) · ISRN Immunology · doi:10.1155/2014/524081 · Cited by 14
Self-citationDjoumerska‐Alexieva, I., Dimitrov, J. D., Nacheva, J., Kaveri, S. V., & Vassilev, T. L. (2009) · Autoimmunity · doi:10.1080/08916930902832181 · Cited by 14
Huang, T., Chen, X., Gu, H., Zhao, C., Liu, X., Yan, M., Deng, X., Zhang, Z., & Gu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9085 · Cited by 14
IVIG efficacy in CIDP patients is not associated with terminal complement inhibition
Keller, C. W., Quast, I., Dalakas, M. C., & Lünemann, J. D. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.02.001 · Cited by 14
Lewis, B. J. B., Villé, J., Blacquiere, M., Cen, S. Y., Spirig, R., Zuercher, A. W., Käsermann, F., & Branch, D. R. (2019) · BMC Immunology · doi:10.1186/s12865-019-0328-6 · Cited by 14
Engineered Fc-glycosylation switch to eliminate antibody effector function
Zhou, Q., Jaworski, J. A., Zhou, Y., Valente, D., Cotton, J., Honey, D. M., Boudanova, E., Beninga, J., Rao, E., Wei, R. R., et al. (2020) · mAbs · doi:10.1080/19420862.2020.1814583 · Cited by 14
Alavi, A., Fraser, O. P., Tarelli, E., Bland, M., & Axford, J. S. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.263 · Cited by 14
Strohl, W. R. (2011) · Modecular medicine and medicinal · doi:10.1142/9781848166295_0005 · Cited by 13
Identification of serum glycobiomarkers for Hepatocellular Carcinoma using lectin microarrays
Zhang, Y., Zhang, S., Liu, J., Zhang, Y., Liu, Y., Shen, S., Tian, F., Yan, G., Gao, Y., & Qin, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.973993 · Cited by 13
Liou, L.-B., & Huang, C.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151669 · Cited by 13
Emerging immunotherapies for autoimmune kidney disease
Foster, M. H., & Ord, J. R. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1555569 · Cited by 12
The Role and Function of Fcγ Receptors on Myeloid Cells
Bournazos, S., Wang, T. T., & Ravetch, J. V. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch22 · Cited by 13
Self-citationPark, J. S., Choi, H. J., Jung, K. M., Lee, K. Y., Shim, J. H., Park, K. J., Kim, Y., & Han, J. Y. (2023) · Communications Biology · doi:10.1038/s42003-023-04937-5 · Cited by 13
Vanderschaeghe, D., Debruyne, E., Vlierberghe, H. V., Callewaert, N., & Delanghe, J. (2009) · Electrophoresis · doi:10.1002/elps.200900054 · Cited by 13
Rapid Glycopeptide Enrichment Using Cellulose Hydrophilic Interaction/Reversed-Phase StageTips
Ohta, Y., Kameda, K., Matsumoto, M., & Kawasaki, N. (2017) · Mass Spectrometry · doi:10.5702/massspectrometry.a0061 · Cited by 13
IgG glycosylation in autoimmune diseases
Kozłowska, K., Rydlewska, M., Ząbczyńska, M., & Pocheć, E. (2018) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0012.7351 · Cited by 13
Sweet Rules: Linking Glycosylation to Antibody Function
Nimmerjahn, F., & Werner, A. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_12 · Cited by 12
Self-citationHuman IgG Subclasses Differ in the Structural Elements of Their N -Glycosylation
Wang, W., Maliepaard, J. C. L., Damelang, T., Vidarsson, G., Heck, A. J. R., & Reiding, K. R. (2024) · ACS Central Science · doi:10.1021/acscentsci.4c01157 · Cited by 12
Marqvorsen, M. H. S., Araman, C., & van Kasteren, S. I. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00588 · Cited by 12
Li, M., Zhu, W., Zheng, H., & Zhang, J. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339232 · Cited by 12
Aptamer-based Biosensors: Promising Sensing Technology for Diabetes Diagnosis in Biological Fluids
Khoshbin, Z., Shakour, N., Iranshahi, M., Butler, A. E., & Sahebkar, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220829150118 · Cited by 12
Engineering the supernatural: monoclonal antibodies for challenging infectious diseases
Grace, P. S., Gunn, B. M., & Lu, L. L. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102818 · Cited by 11
Sam, N. T., Misaki, R., Ohashi, T., & Fujiyama, K. (2018) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2018.01.010 · Cited by 12
Chen, C., Lin, Y., Ren, C., Shivatare, S. S., Lin, N.-H., Wu, C., Chen, C., & Lin, J. (2020) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461610 · Cited by 12
Virus Infection of the Heart – Unmet Therapeutic Needs
Hazebroek, M. R., Dennert, R. M., & Heymans, S. R. B. (2012) · Antiviral chemistry & chemotherapy · doi:10.3851/imp2047 · Cited by 12
Blundell, P. A., Lu, D., Wilkinson, M., Dell, A., Haslam, S., & Pleass, R. J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801337 · Cited by 11
The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors
Jones, A., Marino, A. E., Martynyuk, T., Bournazos, S., & Ravetch, J. V. (2025) · Science · doi:10.1126/science.adv2927 · Cited by 11
Self-citationAzzoni, L., Giron, L. B., Vadrevu, S. K., Zhao, L., Lalley-Chareczko, L., Hiserodt, E., Fair, M. G., Lynn, K., Trooskin, S. B., Mounzer, K., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4a1221-678rr · Cited by 12
Luley, C., Schmoelzer, K., Thomann, M., Malik, S., Greif, M., Ribitsch, D., Jung, C. J., Sobek, H., Engel, A. M., Mueller, R., et al. (2016) · Glycobiology · doi:10.1093/glycob/cww046 · Cited by 11
The role of ACPAs in at-risk individuals: Early targeting of the bone and joints
Schett, G. A. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.015 · Cited by 11
Guan, X., Chaffey, P. K., Chen, H., Feng, W., Wei, X., Yang, L.-M., Ruan, Y., Wang, X., Li, Y., Barosh, K. B., et al. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00875 · Cited by 11
Sahin, M., Remy, M. M., Fallet, B., Sommerstein, R., Florova, M., Langner, A., Klausz, K., Straub, T., Kreutzfeldt, M., Wagner, I., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110303 · Cited by 10
Jia, Y., Ren, S., Song, L., Wang, S., Han, W., Li, J., Yu, Y., & Ma, B. (2023) · iScience · doi:10.1016/j.isci.2023.106653 · Cited by 10
Quast, I., Keller, C. W., Weber, P., Schneider, C., von Gunten, S., & Lünemann, J. D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0506-x · Cited by 11
Effects of Galactosylation in Immunoglobulin G from All-Atom Molecular Dynamics Simulations
Fortunato, M., & Colina, C. M. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp504243e · Cited by 11
Possible role of β-galactosidase in rheumatoid arthritis
Su, Z., Gao, J., Xie, Q., Wang, Y., & Li, Y. (2019) · Modern Rheumatology · doi:10.1080/14397595.2019.1640175 · Cited by 11
Heat-induced stress modulates cell surface glycans and membrane lipids of coral symbionts
Tortorelli, G., Rosset, S. L., Sullivan, C., Woo, S., Johnston, E. C., Walker, N., Hancock, J. R., Caruso, C., Varela, A. C., Hughes, K. M., et al. (2025) · The ISME Journal · doi:10.1093/ismejo/wraf073 · Cited by 10
Kang, J., Lim, S.-J., Kwon, O., Lee, S., Kim, H. H., & Oh, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133739 · Cited by 10
Neuraminidase Inhibitor Zanamivir Ameliorates Collagen-Induced Arthritis
Sehnert, B., Mietz, J., Rzepka, R., Buchholz, S., Maul‐Pavicic, A., Schaffer, S., Nimmerjahn, F., & Voll, R. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031428 · Cited by 10
Self-citationCrowley, A. R., Osei‐Owusu, N. Y., Dekkers, G., Gao, W., Wuhrer, M., Magnani, D. M., Reimann, K. A., Pincus, S. H., Vidarsson, G., & Ackerman, M. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.754710 · Cited by 11
Deml, L., Hüber, C. M., Barabas, S., Spindler, T., Cozzi, E., & Grossi, P. (2021) · Transplantation Direct · doi:10.1097/txd.0000000000001236 · Cited by 10
Cornet-Gómez, A., Moreira, L. R., Gómez-Samblás, M., & Osuna, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1215913 · Cited by 10
Application of Quality by Design Paradigm to the Manufacture of Protein Therapeutics
del Val, I. J., Philip, M., Exley, K., Sou, S. N., Kyriakopoulos, S., Polizzi, K. M., & Kontoravdi, C. (2012) · InTech eBooks · doi:10.5772/50261 · Cited by 12
Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia
Chen, Y., Zhou, Y., Zhao, N., Zhang, Y., Xu, W., & Tang, Y. (2019) · Cytokine · doi:10.1016/j.cyto.2019.05.014 · Cited by 10
Pilling, D., Karhadkar, T. R., & Gomer, R. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244762 · Cited by 11
A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
Elsanhoury, A., Tschöpe, C., & Linthout, S. V. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10025-4 · Cited by 10
Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation
Beneduce, C., Nguyen, S. A., Washburn, N., Schaeck, J. J., Meccariello, R., Holte, K., Ortiz, D., Manning, A. M., Bosques, C. J., & Kurtagic, E. (2023) · Cells · doi:10.3390/cells12172130 · Cited by 10
Hu, Q., & Wu, H. (2024) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.4c00014 · Cited by 9
Chen, X., Balmer, L. A., Lin, K., Cao, W., Huang, Z., Chen, X., Song, M., & Chen, Y. (2025) · The EPMA Journal · doi:10.1007/s13167-025-00410-x · Cited by 9
Jiang, P., Huang, Y., Reyes, C. D. G., Zhong, J., & Mechref, Y. S. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c03118 · Cited by 9
Gouilleux‐Gruart, V., SCHLEINITZ, N., & Fischer, A. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000433133.93564.c7 · Cited by 9
Néron, S., Boire, G., Dussault, N., Racine, C., de Brum-Fernandes, A. J., Côté, S., & Jacques, A. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0048-3 · Cited by 9
Mgat2 ablation in the myeloid lineage leads to defective glycoantigen T cell responses
Ryan, S. O., Leal, S. M., Abbott, D. W., Pearlman, E. M., & Cobb, B. A. (2013) · Glycobiology · doi:10.1093/glycob/cwt107 · Cited by 9
de Haan, N., Reiding, K. R., & Wuhrer, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6493-2_5 · Cited by 9
Palomo, V., Cistrone, P. A., Zhan, N., Palui, G., Mattoussi, H. M., & Dawson, P. E. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00477 · Cited by 9
Krumb, M., Jäger, M., Voss, A., Immig, L., Peters, K., Kowalczyk, D., Bufe, A., Opatz, T., Holst, O., Vogel, C., et al. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202002287 · Cited by 9
Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity
Opdenakker, G., & Damme, J. V. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.01.004 · Cited by 9
Shen, Z.-D., Wang, Y.-H., Xu, H.-R., Zhang, Q., Sha, C.-J., Sun, B.-P., & Li, Q. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.03.020 · Cited by 11
Mass spectrometry-based analysis of IgG glycosylation and its applications
Liu, X., Sun, Z., Li, Z., Zhang, Y., & Lu, H. (2022) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2022.116799 · Cited by 9
Emerging glycobiology tools: A renaissance in accessibility
Oswald, D. M., & Cobb, B. A. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.04.010 · Cited by 9
Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions
Dall’Olio, F., & Malagolini, N. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_10 · Cited by 9
Leeuw, E. D., Justesen, J. F., Bosteels, C., Debeuf, N., Vanheerswynghels, M., Jonckheere, L., Wolf, C. D., Wayenberg, A., Damme, K. F. A. V., Vanhee, S., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adz4626 · Cited by 8
Chandel, S., Joon, A., Kaur, S., & Ghosh, S. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12321-2 · Cited by 8
Gupta, P., Sághy, T., Nordqvist, J., Nilsson, J. A., Carlsten, H., Horkeby, K., Henning, P., & Engdahl, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1243942 · Cited by 8
Enomoto, N., Chida, K., Suda, T., Kaida, Y., Taniguchi, M., Azuma, A., Hayashi, H., Ogura, T., Kitamura, H., Yamaguchi, O., et al. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12281 · Cited by 8
Glycosylation des autoanticorps au cours des maladies auto-immunes
Goulabchand, R., Batteux, F., & Guilpain, P. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2013.09.005 · Cited by 8
Sordé, L., Spindeldreher, S., Palmer, E., & Karle, A. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186046 · Cited by 8
Lewis, B. J. B., Leontyev, D., Neschadim, A., Blacquiere, M., & Branch, D. R. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13144 · Cited by 8
Ercan, A. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2005-7 · Cited by 8
Metadata
- Authors
- Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2008-04-18
- Volume
- 320
- Issue
- 5874
- Pages
- 373-376
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2409116
- OpenAlex
- W2051666192
- Cited by
- 849
- References
- 34
- Citations by year
- 2026: 19 · 2025: 32 · 2024: 29 · 2023: 37 · 2022: 39 · 2021: 39 · 2020: 50 · 2019: 39 · 2018: 45 · 2017: 46 · 2016: 66 · 2015: 58 · 2014: 58 · 2013: 58 · 2012: 68
- FWCI
- 42.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01gm060938-10)
- National Institute of General Medical Sciences (R01GM054045, R01-GM060938, GM60938)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- intravenous immunoglobulin, anti-inflammatory activity, IgG Fc fragment, sialylation, N-glycans, glycan engineering, autoimmune disease
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Arthritis, Experimental, Autoimmune Diseases, Carbohydrate Conformation, Galactose, Glycosylation, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Mice, Inbred C57BL, Polysaccharides, Receptors, Fc, Recombinant Proteins, Purpura, Thrombocytopenic, Idiopathic, Mice, Inbred NOD, Immunoglobulins, Intravenous, N-Acetylneuraminic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review